Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Fish and Richardson
Cipla
US Department of Justice
Medtronic
UBS
Argus Health
Merck
Covington
Deloitte

Generated: October 19, 2017

DrugPatentWatch Database Preview

Fosinopril sodium; hydrochlorothiazide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for fosinopril sodium; hydrochlorothiazide and what is the scope of fosinopril sodium; hydrochlorothiazide freedom to operate?

Fosinopril sodium; hydrochlorothiazide
is the generic ingredient in two branded drugs marketed by Mylan, Actavis Labs Fl Inc, Emcure Pharms India, Invagen Pharms, Sun Pharm Inds Ltd, Watson Labs, Aurobindo Pharma, Teva, Sandoz, and Bristol Myers Squibb, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for fosinopril sodium; hydrochlorothiazide. Eight suppliers are listed for this compound.

Summary for Generic Name: fosinopril sodium; hydrochlorothiazide

US Patents:0
Tradenames:2
Applicants:10
NDAs:10
Drug Master File Entries: see list6
Suppliers / Packagers: see list8
Clinical Trials: see list2,693
Drug Prices:see low prices
DailyMed Link:fosinopril sodium; hydrochlorothiazide at DailyMed

Pharmacology for Ingredient: fosinopril sodium; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb
MONOPRIL-HCT
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL020286-001Nov 30, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe
Sandoz
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL076961-002Sep 28, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL076608-001Dec 3, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL076739-001Dec 17, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Emcure Pharms India
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL079025-001Sep 17, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL077144-002Aug 16, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL079245-002Jul 9, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL076608-002Dec 3, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL077705-002Aug 14, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL076739-002Dec 17, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: fosinopril sodium; hydrochlorothiazide

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Federal Trade Commission
Dow
Healthtrust
Novartis
Harvard Business School
Accenture
UBS
Deloitte
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot